evenfolio

IT · NSE: FRACTAL

Fractal Analytics

Q2 FY27 earnings and concall highlights

Price as of 16 Nov 2026
803.10−3.33%

Q2 FY27 earnings call · Guided by management

Call held 4 Nov 2026 · Read the filing on NSEFiling

22​%EBITDA marginVelamakanni · Q&A · p. 15
100​USD millionProduct revenue run rate · productsVelamakanni · Q&A · p. 16
₹81​CrIPO proceeds utilised · Q2 FY 2027Kedia · p. 7
31​%Holding in Qure.ai · Qure.aiVelamakanni · Q&A · p. 18
M.Cap
₹13,914Cr
P/E
37.0×
1Y return
—
From 52W high
−28.2%

Highlights are read by AI from the company's filing and can contain mistakes. Check the source page linked to each line.

Share price

Results Q2 FY27, as filed · consolidated · ₹ Cr

Q2 FY27Year agoYoYQ1 FY27QoQ
Revenue957——913+4.8%
EBITDA150——143+5.0%
EBITDA margin15.7%——15.7%+3 bps
One-off items———7—
PBTProfit before tax126——121+4.6%
Net profit81——74+9.4%
EPS (₹)4.48——4.09+9.5%

From the company's own results filing on NSE. Net profit is the owners' share. Growth and the dotted lines are worked out from the filed figures.

Guidance

Revenue · products100 USD millionProduct revenue aim of about $100 million run rate in about 12 quarters
EBITDA margin · long term22%Aim to take EBITDA close to 22% while maximising revenue growth

DSO expected to return to historical range by end of the year

Shilpa Kedia · Chief Financial Officer · p. 7
“This was mainly a timing effect of collections moving into the next quarter. We expect DSO to return to its historical range by the end of the year.”

Gross margins expected to recover significantly in Q3 and Q4

Srikanth Velamakanni · Co · Q&A · p. 9
“Net-net, we think gross margins will recover quite significantly in Q3 and Q4, and some of these investments are very important investments for when enterprise AI really takes off in a very big way.”

Profitability expected to improve over next two quarters and all of next fiscal

Srikanth Velamakanni · Co · Q&A · p. 12
“We feel we are on track to improving profitability, not just these next two quarters, but all of next fiscal as well. We expect SG&A operating leverage to continue to play an important role in the overall profitability improvement.”

Fractal Alpha: Fractal Alpha to approach breakeven by end of this year, break even next year

Srikanth Velamakanni · Co · Q&A · p. 13
“So sequentially, we expect growth to be robust and at higher margin and so the overall profitability is trending in the right direction for the next two quarters, and by the end of this year, we will be approaching breakeven. Certainly, next year we will break even on the products on the Alpha segment.”

Decent improvement in overall profitability expected by Q4 this year

Srikanth Velamakanni · Co · Q&A · p. 12
“Those healthy profitability levels are kind of within arm’s length right now. We are continuing to improve, and even by Q4 this year, we should have a decent improvement in overall profitability.”

More figures from the call

products · Segments
4​%Product share of revenue · next few quarters
“As long as it is that 4% is going to five and then six and seven, and it is trending in that direction, it does not have to be necessarily. The CAGR will take care of itself as long as it is meaningfully increasing in the next few quarters sequentially and as a part of overall revenue.”
Srikanth Velamakanni · Co · Q&Ap. 17

In short

  1. 01Q2 revenue was Rs 957 crore, up 20% year on year (10% in constant currency).
  2. 02Adjusted EBITDA margin was 16.2%; management targets EBITDA close to 22% while maximising growth.
  3. 03Gross margin fell to 44% on AI engineering hiring; management expects it to recover in Q3 and Q4.
  4. 04Products run rate is above Rs 150 crore; aim is about a $100 million run rate in about 12 quarters.
  5. 05Fractal Alpha expected to approach breakeven by end of this year and break even next year.
  6. 06Cash was Rs 1,728 crore; M&A pipeline described as active, with deals expected soon.

Order book

products: Product remaining performance obligations above Rs 200 crore

Srikanth Velamakanni · Co · p. 4
“In addition, our remaining performance obligations, RPO, which is defined as contracted revenue yet to be delivered and recognized for products, stands at over INR 200 crore.”

Segments

healthcare and life sciences (HLS): Healthcare and life sciences grew 79% year on year

Srikanth Velamakanni · Co · p. 3
“Our healthcare and life sciences (HLS) business continued to be the growth leader, growing at an exceptional 79% year-over-year.”

technology, media & telecom (TMT): TMT said to have bottomed out; grew 6% sequentially

Srikanth Velamakanni · Co · p. 3
“As I said in the last quarter, technology, media & telecom (TMT) has bottomed out. It grew sequentially by 6%, though it remains a sector going through a lot of change.”

others: Energy, travel and industrial clients (others) grew 47% year on year

Srikanth Velamakanni · Co · p. 4
“Our energy, travel, and industrial clients, which we report as “others”, grew 47% year-over-year.”

geographies: Americas grew 22%, Europe 20%, APAC 7% year on year

Srikanth Velamakanni · Co · p. 4
“Americas led the revenue growth with 22%, while Europe was close behind with 20% growth. APAC grew by 7% year-over-year.”

products: Product revenue Rs 38 crore (4%); run rate above Rs 150 crore, up 39%

Srikanth Velamakanni · Co · p. 4
“Our products revenue is at INR 38 crore for the quarter, which is 4% of our overall revenue. Our products portfolio is now at a run rate of more than INR 150 crore a year, up 39% year-over-year.”

Demand

Net Promoter Score was 76

Srikanth Velamakanni · Co · p. 4
“our Net Promoter Score was 76, which tells us that our clients are very satisfied with our work and want to work with us more.”

Net Revenue Retention 115% in Q2, up from 112% last year

Srikanth Velamakanni · Co · p. 4
“Our Net Revenue Retention was 115% in Q2, up from 112% last year, and new clients added another five points of growth.”

58 clients above $1 million annual revenue, 20 above $5 million

Srikanth Velamakanni · Co · p. 4
“we now have 58 clients with more than $1 million in annual revenue, and 20 of them are above $5 million.”

Six clients above $20 million each, up from four a year ago

6​clients
Srikanth Velamakanni · Co · p. 5
“Now, six clients bring in more than $20 million each, up from four a year ago.”

About one new client added every 10 days

Srikanth Velamakanni · Co · p. 5
“Our new client additions continue to be healthy at about one new client every 10 days.”

Margins and costs

Gross margin 44%, down 225 bps, due to hiring AI research and engineering talent

Srikanth Velamakanni · Co · p. 4
“Gross margin was at 44%, down 225 basis points year-over-year, mainly because we invested in developing precious AI research and AI engineering talent ahead of growth.”

Merit increases cut gross margin 216 bps; weaker rupee added 270 bps

Shilpa Kedia · Chief Financial Officer · p. 6
“Annual merit increases had a negative impact of 216 basis points, while the weaker rupee provided a benefit of 270 basis points.”

Adjusted EBITDA margin 16.2%, up 123 bps year on year

Shilpa Kedia · Chief Financial Officer · p. 6
“adjusted EBITDA margin for Q2 FY 2027 was 16.2%, with expansion of 123 basis points versus Q2 FY 2026.”

SG&A grew 5% but fell to 23.6% of revenue from 27%

Shilpa Kedia · Chief Financial Officer · p. 6
“While in absolute, it grew by 5%, as a percentage of revenue, it fell from 27% in Q2 FY 2026 to 23.6% in Q2 FY 2027.”

Of Rs 60 crore R&D, Rs 40 crore expensed, rest capitalised; mostly Cogentiq and Asper.ai

Shilpa Kedia · Chief Financial Officer · p. 6
“Of the INR 60 crore, INR 40 crore was expensed, the rest was capitalized. Most of this investment goes into building Cogentiq and Asper.ai.”

Debt and working capital

Trailing 12-month operating cash flow Rs 407 crore, up 11%

Shilpa Kedia · Chief Financial Officer · p. 7
“Our cash flow from operations was INR 407 crore on a trailing 12-month basis, which grew by 11% year-over-year.”

H1 operating cash outflow Rs 24 crore due to variable pay in Q1

Shilpa Kedia · Chief Financial Officer · p. 7
“Overall, our H1 2027 cash flow from operations is negative INR 24 crore due to payout of variable compensation in Q1 2027.”

DSO rose by five days to 76 days from 71 days

Shilpa Kedia · Chief Financial Officer · p. 7
“Days sales outstanding (DSO) has increased by five days to 76 days in Q2 2027 versus 71 days in Q2 2026.”

Cash and equivalents Rs 1,728 crore, including Rs 608 crore IPO proceeds

Shilpa Kedia · Chief Financial Officer · p. 7
“As of 30 September 2026, we had cash and cash equivalents, including mutual funds and fixed deposits, of INR 1,728 crore, including IPO proceeds of INR 608 crore.”

Acquisitions and new business

Asper.ai: Asper.ai did a capital-light deal with European firm Pricing One

Shilpa Kedia · Chief Financial Officer · p. 6
“Asper.ai has done a capital-light transaction this month with the European firm Pricing One. This transaction provides Asper.ai with a focused foothold in Europe.”

M&A pipeline described as decent; Board keen; deals expected

Srikanth Velamakanni · Co · Q&A · p. 15
“As far as M&A is concerned, Suyash, we are quite active. We have a very decent pipeline, and our Board is very keen also to explore this dimension.”

Pricing One deal described as an acqui-hire; more deals expected

Srikanth Velamakanni · Co · Q&A · p. 15
“For example, we just did Pricing One thing, which is more of an acqui-hire, but we expect that more deals will come through.”

Management expects to do some deals very soon

Srikanth Velamakanni · Co · Q&A · p. 16
“We are looking at a lot of these deals right now, and we expect to do some stuff very, very soon.”

M&A pipeline described as healthy; balance sheet strong; M&A lever to be used

Srikanth Velamakanni · Co · p. 5
“Our M&A pipeline is healthy, and our balance sheet is strong. It’s an opportune time to use the M&A lever to strengthen our right to win.”

Management

Shilpa Kedia joined as Chief Financial Officer last month

Srikanth Velamakanni · Co · p. 5
“I am delighted to welcome Shilpa Kedia, who joined us as Chief Financial Officer last month.”

Leadership changes under way to raise the bar on the team

Srikanth Velamakanni · Co · p. 5
“The third thing I am excited about is the leadership changes we are making. We are consciously raising the bar on our team, and we are finding exceptional people who want to build Fractal with us.”

Risks

Qure.ai: USAID shutdown hurt Qure.ai revenue

Srikanth Velamakanni · Co · Q&A · p. 17
“That was a huge blow to the overall, let us say, health of the globe, and certainly it also had an impact on Qure.ai’s revenue.”

Other

Q2 revenue Rs 957 crore, up 20% year on year and 5% quarter on quarter

Shilpa Kedia · Chief Financial Officer · p. 5
“Revenue was INR 957 crore, up 20% year-over-year and 5% quarter-over-quarter.”

Constant currency revenue growth 10% year on year, 4% quarter on quarter

Shilpa Kedia · Chief Financial Officer · p. 5
“In constant currency terms, growth was 10% year-over-year and 4% quarter-over-quarter.”

Net income up 139% to Rs 79 crore; margin rose from 4% to 8%

Srikanth Velamakanni · Co · p. 4
“Net income grew 139% to INR 79 crore, and net income margin rose from 4% to 8%.”

Net income excluding associate loss Rs 102 crore, 10.7% of revenue

Shilpa Kedia · Chief Financial Officer · p. 6
“Excluding the share of loss from associate, net income for Q2 2027 is INR 102 crore or 10.7% of revenue.”

Qure.ai: Share of Qure.ai loss Rs 23 crore; Qure.ai revenue Rs 28 crore, up 82%

Shilpa Kedia · Chief Financial Officer · p. 7
“That share of loss for us was INR 23 crore for Q2 2027. Qure.ai continues its growth momentum with revenue of INR 28 crore in Q2 2027, with 82% growth year-over-year.”

Sources

Management's own statements, quoted from its NSE filings. This page was read by AI and can contain mistakes: check the source pages before relying on any figure. No forecast or opinion of ours. Not investment advice.

Search

Search funds, ETFs, stocks, pages and tools